ℹ️
🇬🇧
Search
Search for people relevant for "Reductase"
Reductase
Person
Class
Person
Publication
Programmes
Export current view
PharmDr. Ondřej Holas Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
2 classes
53 publications
Class
class
Physical Principles of Dosage Forms
+1
GAPS308 |
Faculty of Pharmacy in Hradec Králové
Publications
publication
Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation
2017 |
Faculty of Pharmacy in Hradec Králové
publication
Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices
2022 |
Faculty of Pharmacy in Hradec Králové
publication
The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier
2021 |
Faculty of Pharmacy in Hradec Králové
publication
Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS)
2021 |
Faculty of Pharmacy in Hradec Králové
publication
PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System
2021 |
Faculty of Pharmacy in Hradec Králové
publication
3 beta-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3 alpha-epimer by hepatic metabolism
2020 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové, Faculty of Science
publication
Branched PLGA derivatives with tailored drug delivery properties
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Nanomaterials for direct and indirect immunomodulation: A review of applications
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Stilbene compound trans-3,4,5,4'-tetramethoxystilbene, a potential anticancer drug, regulates constitutive androstane receptor (Car) target genes, but does not possess proliferative activity in mouse liver
2019 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Load more publications (43)
Loading network view...